← Back to the studies fieldPERMANENT CTIS TRIAL DOSSIER

2025-521385-10-00

ENDO-67 project: Investigating ENDOcrine therapy-related questions using Ki67 changes in the window-of-opportunity before breast surgery

Public registry stateAuthorised
CLAIM BOUNDARY

This dossier documents a medicinal trial—not proof of efficacy.

Registration, authorisation of a trial application, trial start, result disclosure and marketing authorisation are different facts. The dossier claims neither clinical efficacy nor safety, deployment or causality.

CTIS record ≠ efficacy ≠ marketing authorisation
REGISTRY FACTS

What CTIS publishes about this trial

EUCT number
2025-521385-10-00
Trial status
Authorised
Sponsor
not published
Trial region
EEA
Phase
6
Trial category
3
Low-intervention trial
yes
Estimated EU start
01 November 2025
Decision date
21 October 2025
Published
22 October 2025
Estimated end
01 November 2030
EXACT AI EVIDENCE

The original text determines inclusion.

Terms count only in allowlisted public CTIS fields. Sponsor, medical condition, phase or a generic software reference alone is not AI evidence.

“What is the concordance between Ki67 percentage measured by the pathologist versus an artificial intelligence (AI) algorithm”
Source field
authorizedApplication.authorizedPartI.trialDetails.trialInformation.trialObjective.secondaryObjectives[2].secondaryObjective
Matched term
artificial intelligence
MEDICAL CONTEXT

Conditions and therapeutic areas

Reported medical conditions

  • Breast cancer

Therapeutic areas

  • Diseases [C] - Neoplasms [C04]4
COUNTRY TRACKS

Every country retains its own published state.

A status in one country is not transferred to another. Decision dates and status histories remain separate source facts.

Netherlands

Authorised
First decision
21 October 2025
Latest decision
21 October 2025
  1. Authorised
  2. Authorised
TRIAL APPLICATIONS

Submission, decision and country state remain separate

IN

INITIAL

Authorised
Trial status
Authorised
Submitted
09 July 2025
Decided
21 October 2025

Decisions21 October 2025 · Authorized

Country statusNetherlands · Authorised

SOURCE-DATED CHRONICLE

Official dates, not an efficacy narrative.

The chronicle sorts published CTIS events. i6eal observation times follow on a separate clock.

  1. Application Submitted

    Application IN · Authorised

  2. Country Assessment

    Netherlands · Application IN · Authorized

  3. Application Status

    Application IN · Authorised

  4. Country Decision

    Netherlands · Application IN · Authorized

  5. Trial Status Observed

    Authorised

Observed by i6eal
First observed
23 Jul 2026, 13:19
Last observed
23 Jul 2026, 15:03
Materially modified
23 July 2026
RESULT DISCLOSURE

Disclosure is a separate registry fact.

No result disclosure is published in this projection. This means neither that results do not exist nor that a deadline has been missed.

PROVENANCE

From the dossier back to the official record

The public CTIS record remains authoritative. The i6eal files are a deterministic, bounded projection.

i6eal (2026): EU AI Studies Monitor, CTIS trial 2025-521385-10-00, data state 23 July 2026. https://i6eal.de/en/tools/ki-studienmonitor/studie/2025-521385-10-00/